Centex Technologies Welcomes Former Texas A&M University System Chancellor John Sharp as Strategic Advisor
With nearly two decades of experience, Centex Technologies provides secure, scalable, and transformative IT solutions for clients across both public and private sectors. The company's expertise includes cybersecurity, IT modernization, cloud infrastructure, application development, digital forensics, and managed services. With teams in five states, Centex Technologies maintains a strong nationwide presence and serves as a trusted partner to federal agencies, state and local governments, higher education institutions, and commercial enterprises.
'We are honored to welcome John Sharp to the Centex Technologies team,' said Abdul Subhani, CEO of Centex Technologies. 'His distinguished record of service, visionary leadership, and deep understanding of state and federal systems make him an ideal strategic partner as we continue to scale our impact and expand our advanced IT solutions nationwide.'
Mr. Sharp brings a wealth of experience to Centex Technologies. As Chancellor of the Texas A&M University System from 2011 to 2025, he oversaw one of the nation's largest university systems and championed major initiatives in education, research, and technology. His previous roles in Texas state government including Texas Comptroller of Public Accounts, Railroad Commissioner, and member of both the Texas House and Senate further cement his reputation as a bold and effective leader.
'After nearly 15 years leading the Texas A&M University System, I'm excited to begin this next chapter with Centex Technologies,' said Sharp. 'Their reputation for innovation, national security work, and commitment to excellence - particularly in cybersecurity, artificial intelligence, and digital forensics reflects the kind of forward-thinking leadership our country needs. I look forward to helping Centex expand its reach and deepen its impact across both the public and private sectors'
ABOUT CENTEX TECHNOLOGIES
Founded in 2006, Centex Technologies is an IT consulting firm specializing in cybersecurity, digital forensics, AI integration, and managed IT solutions. The firm is ISO 9001:2015 certified, SBA 8(a) certified, and serves a wide range of clients across the federal government, state agencies, education systems, and commercial sectors through contract vehicles including GSA MAS, SeaPort NxG, TIPS, and Texas DIR and HUB programs.
Inquiries about this press release can be sent to: Hailey Hunter, Media Coordinator – press@centextech.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0164283d-4bfe-4b0c-b5b3-79af8a39784d
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Food distributor Sysco beats quarterly expectations as US demand improves
-Packaged and fresh food distributor Sysco beat analysts' estimates for fourth-quarter revenue and profit on Tuesday, helped by improvement in its U.S. operations. The company, which supplies to chains such as KFC and Subway, has been grappling with an uneven recovery in restaurant industry traffic as looming economic uncertainties prompted consumers to increasingly cook meals at home. Sysco's U.S. foodservice segment, its largest business, posted sales of $14.76 billion during the quarter ended June 28, up 2.4% over the year earlier. The segment had seen a 0.7% increase in the preceding quarter. The company is also trying to cut costs through measures such as renegotiation of supplier contracts to procure raw materials at lower prices. To lower shipping expenses, it has introduced programs such as "Sysco-to-go", which requires customers to pick up orders directly from its stores. On an adjusted basis, it earned $1.48 per share during the fourth quarter, beating analysts' average estimate of $1.39 per share, according to data compiled by LSEG. Sysco's total sales rose 2.8% to $21.14 billion, also ahead of the estimate of $21.03 billion. The Houston, Texas-based company forecast fiscal 2026 adjusted earnings per share to be between $4.50 and $4.60. Analysts were expecting a profit of $4.67 per share. The company's shares were down 3% in early trading. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@
Yahoo
5 hours ago
- Yahoo
Boeing posts smaller loss as jet deliveries rise
(Reuters) -Boeing reported a smaller second-quarter loss on Tuesday as the U.S. planemaker ramped up jet production and deliveries, recovering from a regulatory crisis and a major strike that halted most production last year. Shares of the company rose 1.5% in premarket trading. After years of grappling with quality issues and production delays on its flagship 737 MAX, Boeing has cautiously ramped up monthly output this year. In May, the company produced 38 737s. Production has been stable since then, according to the company. "As we continue to execute our Safety & Quality Plan, there's more stability in our operations," CEO Kelly Ortberg said in a letter to Boeing employees on Tuesday. The U.S. Federal Aviation Administration had capped the production of Boeing's best selling 737 MAX jets following a mid-air panel blowout in a nearly new jet in January 2024. "We plan to seek FAA approval to increase to rate 42 when our key performance indicators (KPIs) show that we're ready," Ortberg added. It has delivered 206 737 MAX jets through the first half of the year. Wall Street closely tracks aircraft deliveries, because planemakers collect much of their payment when they hand over jets to customers. Boeing also increased 787 production at its plant in Charleston, South Carolina, from five aircraft a month to seven a month. Through the first half of the year, the planemaker has booked 668 orders, or 625 net orders after cancellations and conversions. An improvement in deliveries marks a pivotal step in Boeing's effort to rebound from years of production disruptions and crises that piled on debt, highlighting the urgency of accelerating output to restore financial stability. The planemaker posted a net loss of $612 million, or 92 cents per share, for the quarter through June, compared with $1.44 billion, or $2.33 per share, a year earlier. However, the planemaker continues to face pressure from supply chain disruptions that have delayed production and limited its ability to meet surging aerospace demand. It posted a loss of nearly $12 billion in 2024 due to challenges across its major business units including charges on its defense programs. It also remains exposed to U.S. President Donald Trump's sweeping tariffs, which could increase parts costs and further strain an already fragile supply chain. Boeing's revenue for the quarter through June rose 35% to $22.75 billion. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
